DARE - Dare Bioscience Inc

Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. The company is headquartered in San Diego, California.

52W High

$4.60

52W Low

$1.83

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.14

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-2.07

EV/Revenue (<3 favorable)

490.70

P/S (TTM) (<3 favorable)

751.51

P/B (<3 favorable)

10.75

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

1.03%

Institutions (25–75% balanced)

6.71%

Shares Outstanding

13,479,500

Float

13,337,800

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

-17,701

Gross Profit (TTM)

-14,315,235

EPS (TTM)

-2.16

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

180.80%

ROE (TTM) (>15% strong)

-9.95%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

1.73

Momentum

Bearish momentum

Value

-0.0404

-0.0437

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025